ArticleCureus2025
Amyopathic Dermatomyositis Presenting With Oral Mucocutaneous Lesion and No Muscle Involvement in an Elderly Woman: A Mimicry of Fungal Infection and Eczema.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amyopathic dermatomyositis (ADM) is a rare subtype of dermatomyositis defined by characteristic cutaneous findings without clinical or laboratory evidence of muscle involvement for at least six months. Although lacking myopathy, patients remain at risk for systemic complications, particularly rapidly progressive interstitial lung disease (RP-ILD) in the presence of anti-melanoma differentiation-associated gene 5 (MDA5) antibodies, as well as autoimmune overlap and malignancy. Diagnostic recognition may be delayed due to subtle clinical features and non-specific biopsy results. We report a 76-year-old woman who presented with violaceous papules on the upper and lower extremities, a painless blister on the lateral tongue, and purplish discoloration of the right great toe. Initial biopsy of the oral lesion was non-specific, and differential diagnoses included eczema and fungal infection. Her symptoms persisted despite empiric topical steroids and antifungal therapy. Repeat biopsies and exclusion of muscle disease confirmed ADM. Systemic corticosteroids and hydroxychloroquine were initiated, followed by mycophenolate mofetil, with limited response. The addition of intravenous immunoglobulin (IVIG) resulted in gradual improvement, leading to complete resolution of cutaneous lesions after 18 months, without systemic complications. This case illustrates the atypical presentation of ADM and the challenges in establishing an early diagnosis when muscle involvement is absent. It highlights IVIG as an effective option for treatment-resistant disease and underscores the importance of maintaining a high index of suspicion, pursuing thorough diagnostic evaluation, and ensuring long-term monitoring for interstitial lung disease and malignancy, even in patients who present with isolated cutaneous findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.